, netbic

netbic
Risk

Spain
Translate
0
Followers
0
0userSocialWidget.week
Copiers
No Change

View more

Similar Traders

View More
Medical Marijuana
Medical Marijuana @CannabisCare
Turn on notifications
Flag as spam
Dear Investors, Here is your monthly update for September 2019. The CannabisCare is a thematic portfolio, which means its investment strategy is semi-passive, selecting stocks from the most intriguing fields in biotechnology today- medical cannabis. Each stock within the CopyPortfolio's composition is given equal allocation. The US small growth benchmark index is currently up 16.23% for the year. This portfolio is currently up 5%- well below the index. September was another extremely low performing month, closing with a loss of 10.59%. The only stock that performed well and finished the month with an increase was $ABV which increased by 15%. <a href="/markets/zyne" class="e-link">$ZYNE (Zynerba Pharmaceuticals Inc)</a> and <a href="/markets/cara" class="e-link">$CARA (Cara Therapeutics )</a> were the lowest performers, closing with a loss of 29% and 22% respectively. This CopyPortfolio is a long-term investment vehicle. Therefore, since market trends can change over time, you should set realistic goals and assess your investment performance over a prolonged period. Long-term investment vehicles can go through various market cycles, such as bull markets and market downturns. The risk for this CopyPortfolio stayed the same this month, though still slightly high- as this is currently a very volatile market- some even consider it the cryptocurrency of the stock market. Decreased risk, can mean lower volatility and lower swings both ways in terms of profit and loss. Please bear this in mind. CIBC Capital Markets rated Aurora as neutral with a TP of $7. Read more here: <a href="https://investingnews.com/daily/cannabis-investing/cibc-expands-cannabis-stock-coverage/" class="e-link" target="_blank" rel="noopener noreferrer nofollow ugc">investingnews.com/daily/cannabis-investing/cibc-expands-cannabis-stock-coverage/</a> Please remember past performance is not indicative of any future performance. We will be releasing a new CopyPortfolio, <a href="/people/foodtech" class="e-link">@FoodTech</a>, focusing on food innovation. Feel free to add it to your watchlist. <a href="/markets/crbp" class="e-link">$CRBP (Corbus Pharmaceuticals Holding)</a>, $ISNY, <a href="/markets/cron" class="e-link">$CRON (Cronos Group Inc)</a>, <a href="/markets/gwph" class="e-link">$GWPH (GW Pharmaceuticals Plc)</a>, <a href="/markets/acb" class="e-link">$ACB (Aurora Cannabis Inc)</a>, <a href="/markets/cara" class="e-link">$CARA</a>, <a href="/markets/abbv" class="e-link">$ABBV (AbbVie Inc)</a>, <a href="/markets/smg" class="e-link">$SMG (Scotts Miracle-Gro Company)</a>, <a href="/markets/zyne" class="e-link">$ZYNE</a>, <a href="/markets/tlry" class="e-link">$TLRY (Tilray, Inc.)</a>, <a href="/markets/cgc" class="e-link">$CGC (Canopy Growth Corp)</a> ... Show More
Medical Marijuana
Medical Marijuana @CannabisCare
Turn on notifications
Flag as spam
Coming Soon: New Stocks added to the CannabisCare portfolio Today, September 25th, the CannabisCare portfolio will be updated with new assets as part of maintaining the portfolio strategy, covering the growth of the Medical Cannabis industry. Read below for more information (no action is required on your behalf). Until recently, the word cannabis was something to be discussed behind closed doors. The research advancements in the various applications of medical cannabis have opened a vibrant global discussion about the use of these plants for medical and recreational use. In the beginning, the industry of medical research was left for those with entrepreneurial spirits, while big pharmaceutical companies mostly remained on the sidelines when it came to the use of Cannabis for medical purposes mostly due to regulatory concerns. However, with many of these restrictions being relaxed due to more and more research indicating the benefits of its use, we are beginning to see a rise in M&amp;A activity, patent applications and clinical trials among the largest pharmaceutical companies in the world. In fact, some of the large-cap pharmaceutical companies have taken leading positions in the industry. This shift is an anticipated step in the adoption of innovative technological products and symbolises the growth of the medical cannabis industry. With leading global companies taking front seats, we can expect more significant commitments and accelerated pace of breakthroughs, lobbying efforts, research and academic support etc. As such, eToro’s investment committee has decided to update the CannabisCare portfolio with new companies that reflect the new engagement coming from large-cap companies in this sector. Sanofi <a href="/markets/san.pa" class="e-link">$SAN.PA (Sanofi)</a> and Novartis <a href="/markets/nvs" class="e-link">$NVS (Novartis ADR)</a> were among the leading big pharma companies to register cannabinoid-related clinical trials in the U.S. and Canada, filled numerous patent filings and were both active in the VC and M&amp;A cannabis-related landscape. Aside from diversifying the portfolio with large, traditional pharmaceutical companies, these additions provide a geographical diversification to this North American biased industry/portfolio. Headquartered in France and Switzerland respectively, these pharma giants are expected to support further growth of the medical cannabis industry. Recently (May 2019), eToro presented a unique commercial offering to investors in the form of zero commissions equity investing {available for eToro (Europe) Ltd.’s (CYSEC regulated) clients}. However, all clients from all regions investing in this portfolio will be able to obtain this benefit when investing in this portfolio. From today (25/09/19) all stocks in the portfolio will be opened in the portfolio under the zero commission benefit. This will require closing the current holdings of the portfolio and opening new positions (with the new allocation) under the adjusted weighting. There are no management or additional fees for investing in this portfolio. Please note that these steps do not require any actions on your behalf and the entire process is executed by eToro. The rebalancing will take place on Monday, September 25th, 2019. The minimum investment is $5,000. ... Show More
Omar Sosa Afonso
Omar Sosa Afonso @OmarETSA
Turn on notifications
Flag as spam
Nota informativa 2: Buenas a todos, ya he terminado dw hacer los depositos que tenia pensado, lo que quieran y puedan pueden agregar fondos a la copia, lo que no, no se preocupen, se seguiran copiando todas las operaciones, por eso habia deja un importe del dinero sin operar. Saludos y que tengan un buen dia ... Show More
Translate
Omar Sosa Afonso
Omar Sosa Afonso @OmarETSA
Turn on notifications
Flag as spam
Hola a todos!! No sabia si escribir este mensaje, pero en vista de todos los comentarios que estoy recibiendo me voy a animar a compartirlo. Como los que llevan tiempo en copia conmigo sabrán, desde Junio de este año teníamos abiertas unas posiciones muy fuertes en $NATGAS , que estuvieron gran parte del tiempo en grandes números rojos, todo ello origino una avalancha de comentarios negativos, preguntas para cerrar posiciones, etc. yo por mi parte, comprendía la preocupación de todos, pero instaba a la calma, ya que no es la primera vez que sucede esto (y hasta poco fue), soy consiente de como es mi estrategia, y debo mantener la cabeza fría para conseguir ganancias consistentes. El mejor consejo que es puedo dar es que no dejéis que las emociones os jueguen una mala pasada....los mercados son muy traicioneros, y el control de las emociones juega un papel fundamental. NADIE quiero perder dinero, entre los cuales me incluyo por supuesto, por ello, si mantengo las posiciones o abro mas, etc, es para ganar dinero. MUCHAS GRACIAS A TODOS POR LOS MENSAJES DE FELICITACIONES, son un buen apoyo para mi, seguiremos trabajando duro para ganar dinero. Un saludo ... Show More
Translate
Francisco Simon de Freitas de farias
Francisco Simon de Freitas de farias @simonfarias47
Turn on notifications
Flag as spam
@pau_ninja hola pau , que monto recomiendas invertir para hacer seguimiento ya que el basico de 200 es nulo ... Show More
Translate